Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Inmunological Study to Assess the Rate of Gestation, Abortion and Live Newborn in Patients With Recurrent Abortions and Recurrent Implantation Failure.

NCT04052438 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.

NCT NCT04052438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04052438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Inmunological Study to Assess the Rate of Gestation, Abortion and Live Newborn in Patients With Recurrent Abortions and Recurrent Implantation Failure.
Lead sponsor
IVI Madrid
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
January 31, 2017
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

maternal-fetal kir-hla-c compatibility